基底细胞癌管理临床实践指南
基底细胞癌(BCC)是美国最常见的人类癌症,年发病率持续上升,早期诊断后多数可通过诊室治疗获得高度治愈。本循证指南基于最佳可得文献,为BCC患者的活检技术、组织病理学解读、复发风险分层、治疗方式(从局部药物和浅表破坏性治疗到手术和全身治疗)以及预防和随访提供推荐。
要点
- BCC是美国最常见的人类癌症,年发病率持续上升。
- 早期诊断后多数BCC可通过诊室治疗获得高度治愈。
- 本循证指南为BCC管理提供活检、病理、风险分层、治疗、预防和随访推荐。
核心结论
- 本循证指南为基底细胞癌患者的活检、组织病理学解读、复发风险分层、治疗方式选择、预防和随访提供推荐。
研究设计与样本
- 美国皮肤病学会(J Am Acad Dermatol)制定的循证临床实践指南,基于对最佳可得文献的深入综述。
主要发现
- 基底细胞癌是美国最常见的人类癌症,年发病率持续上升。
- 早期诊断时,大多数基底细胞癌可通过诊室治疗获得高度治愈。
- 在缺乏正式分期系统的情况下,综述了基于复发风险的最佳可得分层。
- 治疗方式涵盖从局部药物和浅表破坏性治疗到手术技术和全身治疗的广泛谱系。
关键数值与推荐
- 指南就临床可疑病变的活检技术提供推荐。
- 指南就基底细胞癌的组织病理学解读提供推荐。
- 指南就基于复发风险的最佳可得分层提供推荐。
- 指南就局部药物、浅表破坏性治疗、手术技术和全身治疗等治疗方式提供推荐。
- 指南就预防和基底细胞癌诊断后患者的适当随访提供推荐。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed.
引用
- Kim JYS, Kozlow JH, Mittal B, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018. PMID: 29331385. doi:10.1016/j.jaad.2017.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。